Pay in 4 interest-free payments of $5.52 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
This does not always reflect dangerously low glucose
For most people focused primarily on weight loss (which is the majority of the GLP-1 user population), tirzepatide is the stronger option based on current evidence
Gastrointestinal side effects can lead to dehydration in some patients, which may increase the risk of acute kidney injury
Check if youre eligible for any manufacturer savings programs If your insurance stopped covering Wegovy or another GLP-1, you may still be eligible to save using the drugs manufacturer savings program
Leonard Glass, senior vice president of global medical affairs at Lilly Cardiometabolic Health, said in the news release
However, the details are different
US$ 25.23
US$ 21.98
US$ 23.37
US$ 22.48
US$ 27.93
US$ 22.96
